TherapeuticsMD (NASDAQ:TXMD) Stock Price Up 1.3% – Still a Buy?

TherapeuticsMD, Inc. (NASDAQ:TXMD)’s share price shot up 1.3% during mid-day trading on Thursday . The stock traded as high as $1.63 and last traded at $1.61. 20,783 shares changed hands during trading, a decline of 87% from the average session volume of 162,892 shares. The stock had previously closed at $1.59.

Analysts Set New Price Targets

Separately, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of TherapeuticsMD in a research note on Monday. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, TherapeuticsMD currently has a consensus rating of “Sell”.

TherapeuticsMD Stock Performance

The company has a 50 day moving average price of $1.33 and a 200 day moving average price of $1.22. The firm has a market cap of $18.63 million, a price-to-earnings ratio of -161.00 and a beta of 0.41.

TherapeuticsMD (NASDAQ:TXMD) last issued its quarterly earnings data on Wednesday, November 12th. The company reported $0.01 earnings per share (EPS) for the quarter. The firm had revenue of $0.78 million during the quarter. TherapeuticsMD had a return on equity of 0.27% and a net margin of 10.80%.

Institutional Investors Weigh In On TherapeuticsMD

An institutional investor recently raised its position in TherapeuticsMD stock. Citadel Advisors LLC lifted its stake in TherapeuticsMD, Inc. (NASDAQ:TXMD) by 125.5% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 34,273 shares of the company’s stock after acquiring an additional 19,073 shares during the quarter. Citadel Advisors LLC owned 0.30% of TherapeuticsMD worth $36,000 at the end of the most recent reporting period. 30.74% of the stock is currently owned by institutional investors.

About TherapeuticsMD

TherapeuticsMD, Inc operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors.